Welcome to CDC stacks | A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation - 13405 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation
  • Published Date:
    Apr 11 2013
  • Source:
    PLoS Negl Trop Dis. 2013; 7(4).
Filetype[PDF-566.97 KB]


No Related Documents.
You May Also Like:
  1. Experiences of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India: An Analysis of Focus Group Discussions with Patients, Families, Community Members and Program Volunteers
    Personal Author:
    Cassidy, Tali; Worrell, Caitlin M.; Little, Kristen; Prakash, Aishya; Patra, Inakhi; Rout, Jonathan; Fox, LeAnne M.;
    Published:
    Feb 05 2016
    Source:
    PLoS Negl Trop Dis. 10(2).
    Description:
    Background : Globally 68 million people are infected with lymphatic filariasis (LF), 17 million of whom have lymphedema. This study explores the effects of a lymphedema management program in Odisha State, India on morbidity and psychosocial effects a...
    File Type:
    Filetype[PDF - 224.99 KB]
  2. Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
    Personal Author:
    Ichimori, Kazuyo; King, Jonathan D.; Engels, Dirk; Yajima, Aya; Mikhailov, Alexei; Lammie, Patrick; Ottesen, Eric A.;
    Published:
    Dec 11 2014
    Source:
    PLoS Negl Trop Dis. 2014; 8(12).
    File Type:
    Filetype[PDF - 1.01 MB]
  3. Implementing Preventive Chemotherapy through an Integrated National Neglected Tropical Disease Control Program in Mali
    Personal Author:
    Dembélé, Massitan; Bamani, Sanoussi; Dembélé, Robert; Traoré, Mamadou O.; Goita, Seydou; Traoré, Mamadou Namory; Sidibe, Abdoul Karim; Sam, Letitia; Tuinsma, Marjon; Toubali, Emily; MacArthur, Chad; Baker, Shawn K.; Zhang, Yaobi;
    Published:
    Mar 20 2012
    Source:
    PLoS Negl Trop Dis. 2012; 6(3).
    Description:
    Background : Mali is endemic for all five targeted major neglected tropical diseases (NTDs). As one of the five ‘fast-track’ countries supported with the United States Agency for International Development (USAID) funds, Mali started to integrate ...
    File Type:
    Filetype[PDF - 873.34 KB]
  4. CDC global health strategy (2012-2015) : 2012 annual progress report
    Corporate Author:
    Center for Global Health (U.S.)
    Published:
    February 2014
    Description:
    The vision of CDC’s global heath strategy is a world where people live healthier, safer, and longer lives through science, policy, partnership, and evidence-based public health action. CDC’s Global Health Strategy was released in 2012, and includ...
    File Type:
    Filetype[PDF - 2.42 MB]
  5. Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation
    Personal Author:
    Chu, Brian K.; Deming, Michael; Biritwum, Nana-Kwadwo; Bougma, Windtaré R.; Dorkenoo, Améyo M.; El-Setouhy, Maged; Fischer, Peter U.; Gass, Katherine; Gonzalez de Peña, Manuel; Mercado-Hernandez, Leda; Kyelem, Dominique; Lammie, Patrick J.; Flueckiger, Rebecca M.; Mwingira, Upendo J.; Noordin, Rahmah; Offei Owusu, Irene; Ottesen, Eric A.; Pavluck, Alexandre; Pilotte, Nils; Rao, Ramakrishna U.; Samarasekera, Dilhani; Schmaedick, Mark A.; Settinayake, Sunil; Simonsen, Paul E.; Supali, Taniawati; Taleo, Fasihah; Torres, Melissa; Weil, Gary J.; Won, Kimberly Y.;
    Published:
    Dec 05 2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(12).
    Description:
    Background : Lymphatic filariasis (LF) is targeted for global elimination through treatment of entire at-risk populations with repeated annual mass drug administration (MDA). Essential for program success is defining and confirming the appropriate en...
    File Type:
    Filetype[PDF - 206.40 KB]